Acute pediatric cannabis intoxication: A scoping review.

This is a scoping review, so it maps what has been written rather than testing whether treatments work or appraising study quality. The included literature was dominated by case reports, series, editorials, and reviews, and the review found three times more narrative reviews, editorials, letters, and commentaries than primary research. Very little evidence addressed the experiences or information needs of clinicians and families: 5 sources addressed healthcare provider experiences or information needs, and 1 addressed parent or family experiences. Race or ethnicity was rarely reported: 92 sources reported children's sex, and 7 mentioned race or ethnicity. Multiple studies used the same data sources, and duplicate case reporting may bias the literature map. Most sources came from the USA, Canada, and France, so findings may not fit other jurisdictions. Prevention strategies were mentioned often, but none evaluated their effectiveness.

The authors declared no potential conflicts of interest. The funding statement names a funder but does not describe a role in design or writing.

Do not read the treatment recommendations, case reports, or flumazenil and dexmedetomidine mentions as evidence that any intervention works. The review found no comparative studies evaluating interventions for acute pediatric cannabis intoxication, and current management was described as based on case reports, observational studies, and clinician judgment.